Reconstructed human epidermis for skin absorption testing: Results of the German prevalidation study

Alternatives to Laboratory Animals

Volumn 34, Issue 3, 2006, Pages 283-294

  Schäfer Korting, Monika ^a   Bock, Udo ^b   Gamer, Armin ^c   Haberland, Annekathrin ^a   Haltner Ukomadu, Eleonore ^b   Kaca, Monika ^b   Kamp, Hennicke ^c   Kietzmann, Manfred ^d   Korting, Hans Christian ^e   Krächter, Hans Udo ^f   Lehr, Claus Michael ^g   Liebsch, Manfred ^h   Mehling, Annette ^f   Netzlaff, Frank ^g   Niedorf, Frank ^d   Rübbelke, Maria K ^e   Schäfer, Ulrich ^g   Schmidt, Elisabeth ^h   Schreiber, Sylvia ^a   Schröder, Klaus Rudolf ⁱ   Spielmann, Horst ^h   Vuia, Alexander ^a   more..

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b ACROSS BARRIERS GMBH   (Germany)

^c BASF SE   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f Department of Intellectual Capital   (Germany)

^g SAARLAND UNIVERSITY   (Germany)

^h FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

ⁱ HENKEL KGAA   (Germany)

Author keywords

Bovine udder skin; Human skin; Human skin models; Percutaneous absorption; Pig skin; Prevalidation; Reconstructed human epidermis; Skin absorption

Indexed keywords

CAFFEINE; TESTOSTERONE;

ARTICLE; EPIDERMIS; EXPERIMENTAL MODEL; GERMANY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN TEST; VALIDATION STUDY;

ANIMALIA; BOS TAURUS; SUS SCROFA;

EID: 33746311297     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290603400312     Document Type: Article

References (51)

1. Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Janusch Roi, A., Prieto, P., Sabbioni, E., Scott, L., Worth, A. & Zuang, V. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-172.
2. OECD (2004). Principles for the Validation, for Regulatory Purposes, of (Quantitative) Structure-Activity Relationship Models. Website http://www. oecd.org/document/23/0,2340,en_2649_34373_33957 015_1_1_1_1,00.html (Accessed 19.4.06).
3. Liebsch, M. & Spielmann, H. (2002). Currently available in vitro methods used in regulatory toxicology. Toxicology Letters 127, 127-134.
4. Spielmann, H. (2003). Validation and regulatory acceptance of new carcinogenicity tests. Toxicologic Pathology 31, 54-59.
5. OECD (2004). OECD Guidelines for the Testing of Chemicals, No. 427: Skin absorption: in vivo method, 8pp. Paris, France: OECD.
6. OECD (2004). OECD Guidelines for the Testing of Chemicals, No. 428: Skin absorption: in vitro method, 8pp. Paris, France: OECD.
7. OECD (2003). Guidance Document for the Conduct of Skin Absorption Studies. Series on testing assessment No. 28. Paris, France: OECD.
8. Lundehn, J. (1992). Uniform principles for safeguarding the health of applicators of plant protection products (uniform principles for operator protection). Mitteilungen aus der Biologischen Bundesanstalt 277, Berlin, Germany.
9. van Ravenzwaay, B. & Leibold, E. (2004). The significance of in vitro rat skin absorption studies to human risk assessment. Toxicology in Vitro 18, 219-225.
10. Onuki, M., Yokoyama, K., Kimura, K., Sato, H., Nordin, R.B., Naing, L., Morita, Y., Sakai, T., Kobayashi, Y. & Araki, S. (2003). Assessment of urinary cotinine as a marker of nicotine absorption from tobacco leaves: a study on tobacco farmers in Malaysia. Journal of Occupational Health 45, 140-145.
11. Ramsey, J.D., Woollen, B.H., Auton, T.R. & Scott, R.C. (1994). The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin. Fundamental and Applied Toxicology 23, 230-236.
12. Frantz, S.W., Ballantyne, B., Beskitt, J.L., Tallant, M.J. & Greco, R.J. (1995). Pharmacokinetics of 2-ethyl-1,3-hexanediol. III. In vitro skin penetration comparisons using the excised skin of humans, rats and rabbits. Fundamental and Applied Toxicology 28, 1-8.
13. Hewitt, P.G., Perkins, J. & Hotchkiss, S.A. (2000). Metabolism of fluroxypyr, fluroxypyr methyl ester, and the herbicide fluroxypyr methylheptyl ester. I: during percutaneous absorption through fresh rat and human skin in vitro. Drug Metabolism and Disposition 28, 748-754.
14. Pont, A.R., Charron, A.R. & Brand, R.M. (2004). Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicology and Applied Pharmacology 195, 348-354.
15. Scott, R.C., Batten, P.L., Clowes, H.M., Jones, B.K. & Ramsey, J.D. (1992). Further validation of an in vitro method to reduce the need for in vivo studies for measuring the absorption of chemicals through rat skin. Fundamental and Applied Toxicology 19, 484-192.
16. Qiao, G.L. & Riviere, J.E. (2002). Systemic uptake and cutaneous disposition of pentachlorophenol in a sequential exposure scenario: effects of skin preexposure to benzo[a]pyrene. Journal of Toxicology and Environmental Health: Part A 65, 1307-1331.
17. Riviere, J.E., Baynes, R.E., Brooks, J.D., Yeatts, J.L. & Monteiro-Riviere, N.A. (2003). Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. Journal of Toxicology and Environmental Health: Part A 66, 133-151.
18. Mahmoud, A., Haberland, A., Dürrfeld, M., Heydeck, D., Wagner, S. & Schäfer-Korting, M. (2005). Cutaneous estradiol permeation, penetration and metabolism in pig and man. Skin Pharmacology and Physiology 18, 27-35.
19. Wagner, S.M., Nogueira, A.C., Paul, M., Heydeck, D., Klug, S. & Christ, B. (2003). The isolated normothermic hemoperfused porcine forelimb as a test system for transdermal absorption studies. Journal of Artificial Organs 6, 183-191.
20. Kietzmann, M., Loscher, W., Arens, D., Maass, P. & Lubach, D. (1993). The isolated perfused bovine udder as an in vitro model of percutaneous drug absorption. Skin viability and percutaneous absorption of dexamethasome, benzoyl peroxide, and etofenamate. Journal of Pharmacological and Toxicological Methods 30, 75-84.
21. Pitterman, W., Kietzmann, M. & Jackwerth, B. (1995). The isolated perfused bovine udder skin. ALTEX 12, 196-200.
22. Netzlaff, F., Lehr, C.M., Wertz, P.W. & Schaefer, U.F. (2005). The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. European Journal of Pharmaceutics and Biopharmaceutics 60, 167-178.
23. Ponec, M., Boelsma, E., Gibbs, S. & Mommaas, M. (2002). Characterization of reconstructed skin models. Skin Pharmacology and Applied Skin Physiology 15, Suppl. 1, 4-17.
24. Liebsch, M., Traue, D., Barrabas, C., Spielmann, H., Uphill, P., Wilkins, S., McPherson, J.P., Wiemann, C., Kaufmann, T., Remmele, M. & Holzhütter, H-G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA 28, 371-401.
25. Spielmann, H., Muller, L., Averback, D., Balls, M., Brendler-Schwaab, S., Castell, J.V., Curren, R., de Silva, O., Gibbs, N.K., Liebsch, M., Lovell, W.W., Merk, H.F., Nash, J.F., Neumann, N.J., Pape, W.J.W., Ulrich, P. & Vohr, H-W. (2000). The second ECVAM workshop on phototoxicity testing. The report and recommendations of ECVAM workshop 42. ATLA 28, 777-814.
26. Lotte, C., Patouillet, C., Zanini, M., Messager, A. & Roguet, R. (2002). Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models. Skin Pharmacology and Applied Skin Physiology 15, Suppl. 1, 18-30.
27. Dreher, F., Fouchard, F., Patouillet, C., Andrian, M., Simonet, J.T. & Benech-Kieffer, F. (2002). Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses. Skin Pharmacology and Applied Skin Physiology 12, Suppl. 1, 40-58.
28. Dreher, F., Patouillet, C., Fouchard, F., Zanini, M., Messager, A., Rouget, R., Cottin, M., Leclaire, J. & Beech-Kieffer, F. (2002). Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol. Skin Pharmacology and Applied Skin Physiology 15, Suppl. 1, 31-39.
29. Gysler, A., Kleuser, B., Sippl, W., Lange, K., Korting, H.C., Höltje, H.D. & Schäfer-Korting, M. (1999). Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharmacological Research 16, 1386-1391.
30. Santos Maia, C., Mehnert, W., Schaller, M., Korting, H., Gysler, A., Haberland, A. & Schäfer-Korting, M. (2002). Drug targeting by solid lipid nanoparticles for dermal use. Journal of Drug Targeting 10, 489-495.
31. Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H.C., Kramer, K.D. & Schäfer-Korting, M. (2004). Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake. Journal of Controlled Release 97, 493-502.
32. Schmook, F.P., Meingassner, J.G. & Billich, A. (2001). Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption. International Journal of Pharmaceutics 215, 51-56.
33. Haberland, A., Schreiber, S., Maia, C.S., Rübbelke, M.K., Schaller, M., Korting, H.C., Kleuser, B., Schimke, I. & Schäfer-Korting, M. (2006). The impact of skin viability on drug metabolism and permeation-BSA toxicity on primary keratinocytes. Toxicology in Vitro 20, 347-354.
34. Schreiber, S., Mahmoud, A., Vuia, A., Rübbelke, M.K., Schmidt, E., Schaller, M., Kandarova, H., Haberland, A., Schaefer, U.F., Bock, U., Korting, H.C., Liebsch, M. & Schäfer-Korting, M. (2005). Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicology in Vitro 19, 813-822.
35. Netzlaff, F., Kostka, K.H., Lehr, C.M. & Schaefer, U.F. (2006). TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. European Journal of Pharmaceutics and Biopharmaceutics 63, 44-50.
36. Kligman, A.M. & Christophers, E. (1963). Preparation of isolated sheets of human stratum corneum. Archives of Dermatology 88, 702-705.
37. DIN (1991). DIN ISO 5725-2: Genauigkeit (Richtigkeit und Präzision) von der Ermittlung der Wiederhole und Vergleichspräzision von festgelegten Messverfahren. Entwurf. Berlin, Germany: Beuth Verlag GmbH.
38. Spielmann, H., Liebsch, M., Döring, B. & Moldenhauer, F. (1994). First results of an EC/COLIPA validation project of in vitro phototoxicity testing methods. ALTEX 11, 22-31.
39. Fentem, J.H. (1999). Validation of in vitro tests for skin corrosivity. ALTEX 16, 150-153.
40. Fentem, J.H. & Botham, P.A. (2002). ECVAM's activities in validating alternative tests for skin corrosion and irritation. ATLA 30, Suppl. 2, 61-67.
41. Kandarova, H., Liebsch, M., Genschow, E., Gerner, I., Traue, D., Slawik, B. & Spielmann, H. (2004). Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX 21, 107-114.
42. Welss, T., Basketter, D.A. & Schröder, K.R. (2004). In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicology in Vitro 18, 231-243.
43. Aeby, P., Wyss, C., Beck, H., Griem, P., Scheffler, H. & Goebel, C. (2004). Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. Journal of Investigative Dermatology 122, 1154-1164.
44. Jacobs, J.J., Lehe, C.L., Cammans, K.D., Das, P.K. & Elliott, G.R. (2004). Assessment of contact allergens by dissociation of irritant and sensitizing properties. Toxicology in Vitro 18, 681-690.
45. van der Sandt, J.J.M., Maas, W.J.M., van Burgsteden, J.A., Sartorelli, P., Montomoli, L., Larese, F., Payan, J-P., Limaset, J.C., Carmichael, P., Kenyon, S., Robinson, E., Dick, I., Nilsen, J., Schaller, K-H., Korinth, G., Cage, S., Wilkinson, S.C. & Williams Faith, M. (2004). In vitro predictions of skin absorption of caffeine, testosterone and benzoic acid: a multi-centre comparison study. Regulatory Toxicology and Pharmacology 39, 271-281.
46. Suhonen, T., Pasonen-Seppänen, S., Kirjavainen, M., Tammi, M., Tammi, R. & Urtti, A. (2003). Epidermal cell culture model derived from rat keratinocytes with permeability characteristics comparable to human cadaver skin. European Journal of Pharmaceutical Sciences 20, 107-113.
47. Baynes, R.E. (2004). In vitro dermal disposition of abamectin (avermectin B[1]) in livestock. Research in Veterinary Science 76, 235-242.
48. Navidi, W.C. & Bunge, A.L. (2002). Uncertainty in measurements of dermal absorption of pesticides. Risk Analysis 22, 1175-1182.
49. Gysler, A., Lange, K., Korting, H.C. & Schäfer-Korting, M. (1997). Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharmacological Research Communications 14, 793-797.
50. COLIPA (1995). Cosmetic Ingredients: Guidelines for Percutaneous Absorption/penetration. 6pp. Brussels, Belgium: COLIPA.
51. Bos, J.D. & Meinardi, M.M. (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology 9, 165-169.